Back to results
US 2023/0143354 A1Published application
Method and drug for treating parkinson's disease
AssigneeTalengen International Limited
InventorJinan LI
Life of this patent
Estimating the term…
Abstract
Provided is a method for preventing and treating Parkinson's disease, including administering to a subject a therapeutically effective amount of a component of a plasminogen activation pathway. The present invention relates to a drug, a pharmaceutical composition, a product and a kit which include the component of the plasminogen activation pathway for treating the described condition.
Claims14
A method for preventing and treating Parkinson's disease, comprising:
- administering a therapeutically effective amount of one or more compounds to a subject with Parkinson's disease, the one or more compounds being selected from the group consisting of:
- a component of a plasminogen activation pathway, a compound capable of directly activating plasminogen or indirectly activating plasminogen by activating an upstream component of the plasminogen activation pathway, a compound mimicking the activity of plasminogen or plasmin, a compound capable of up-regulating the expression of plasminogen or a plasminogen activator, a plasminogen analog, a plasmin analog, a tPA or uPA analog and an antagonist of a fibrinolysis inhibitor.
Dependencies are inferred from the claim text.